Application of euphorbia factor L2 to preparation of medicine for treating rheumatoid arthritis
A technology of euphorbia factor and arthritis, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., and can solve the problems such as the absence of euphorbia factor L2
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1: Pharmacodynamic Study of Euphorbia Factor L2 in Treating Rheumatoid Arthritis
[0025] 1. Experimental method
[0026] Arthritis-susceptible K / BxN model mice were obtained by crossing K / B mice with NOD / Lt mice. The peripheral blood of K / BxN mice aged 6-8 weeks was collected and centrifuged at 4000rpm for 15min to prepare serum. Thirty-six 8-week-old male C57BL / 6N mice were randomly divided into three groups: normal control group, model group and euphorbia factor L2 treatment group. Serum-induced arthritis (SIA) model (Serum-induced arthritis, SIA) was established by intraperitoneal injection of 150 μl K / BxN mouse serum, and the day of injection was recorded as d 0 day. The intraperitoneal injection of euphorbia factor L2 (40 mg / kg) was started one day before modeling, and the administration was continued every day until the end of the experiment. The thickness of the hind paws and ankle joints of the mice was measured every day to evaluate the development ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com